Foghorn Therapeutics Inc. · NASDAQ:FHTX

Foghorn Therapeutics Inc. financial statements

Foghorn Therapeutics Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue30.9M22.6M34.2M19.2M1.32M430.0K00
Cost of revenue3.33M3.12M109.7M19.2K7.51M57.7M1.79M379.0K
Gross profit27.6M22.6M34.2M19.2M1.32M-57.3M-1.79M-379.0K
Research and development85.5M94.5M109.7M105.6M80.3M57.7M44.4M21.2M
Selling, general and administrative27.6M28.4M32.4M30.7M21.7M11.2M6.72M4.82M
Operating income-86.4M-102.7M-107.9M-117.1M-100.7M-68.5M-51.1M-26.0M
Depreciation and amortization3.33M3.12M3.45M3.32M3.23M1.33M693.0K379.0K
EBITDA-83.1M-99.6M-104.5M-113.8M-97.5M-67.2M-50.4M-25.7M
Interest expense11.6M1.91M979.0K540.0K371.0K
Income before tax-74.3M-86.6M-94.2M-108.9M-101.3M-68.8M-51.1M-26.3M
Income tax004.23M01.91M0083.0K
Net income-74.3M-86.6M-98.4M-108.9M-101.3M-68.8M-51.1M-26.3M
Earnings per share, basic-1.18-1.58-2.34-2.62-2.73-6.23-12.20-1.34
Earnings per share, diluted-1.18-1.58-2.34-2.62-2.73-6.23-12.20

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents80.9M55.5M80.3M52.2M101.1M92.8M15.0M40.0M
Short-term investments78.0M188.3M153.7M293.6M53.2M93.0M
Receivables2.38M300.0M842.0K
Inventory-353.2M
Current assets163.2M249.6M240.2M351.4M459.6M190.7M16.9M40.4M
Property, plant and equipment49.4M56.1M19.5M2.68M2.09M
Total assets198.1M284.0M285.9M404.9M519.8M255.6M22.3M43.1M
Accounts payable4.27M3.79M6.26M5.41M3.82M3.68M3.44M2.01M
Current liabilities59.7M67.0M58.4M55.2M48.7M18.8M12.7M3.46M
Long-term debt019.7M11.0M7.03M
Total debt41.3M37.1M45.1M51.5M019.7M15.1M7.03M
Total liabilities306.6M329.5M363.1M404.8M422.9M109.4M23.8M82.3M
Shareholders' equity-108.5M-45.5M-77.2M112.0K96.9M146.2M-88.0M-39.3M
Shares outstanding56.7M55.6M42.3M41.8M41.3M36.8M4.87M19.6M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations-86.1M-100.4M-118.1M193.6M-50.3M-31.3M-46.3M-22.6M
Capital spending-50.0K-906.0K-1.22M-1.21M-3.31M-16.2M-968.0K-1.54M
Free cash flow-86.1M-101.3M-119.3M192.4M-53.6M-47.5M-47.3M-24.2M
Cash from investing112.0M-29.9M144.4M-244.3M36.2M-108.9M-964.0K-1.54M
Cash from financing1.02M105.4M1.78M1.76M22.4M217.5M24.0M51.8M
Share buybacks1.76M43.6M123.3M
Change in cash27.0M-24.9M28.1M-48.9M8.34M77.3M-23.3M27.6M